Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
Grant recipient Haichong Zhang, a biomedical engineer at the school, says his surgical imaging robot will be safer and more accurate than current tests, including ultrasounds and biopsies. Zhang tells The Telegram & Gazette he wants to create a minimally invasive, easily accessible and cost-effective way to better detect prostate cancer, which will affect one-fifth of all men at some point in their lives. Zhang is working on the project with Gregory Fischer, a professor of robotics and mechanical engineering at WPI.

Ex Output:
WPI gets $1.9M grant to help better detect prostate cancer.


Ex Input:
Top doctors fighting Ebola quickly used the case on Tuesday to press the message that people can recover from the potentially deadly disease if they seek proper care. Ebola is dangerous but it is also curable with correct treatment, said Dr. Jean-Jacques Muyembe, director of Congo’s National Institute for Biomedical Research. “Ebola kills quickly and Ebola heals quickly. That’s the message,” said Muyembe, at a press conference in Goma. “These cases were detected very quickly. The husband was infected, he was at home for 10 days and his wife and son were infected,” said Muyembe. “As soon as the response teams detected these cases, they brought them here to the treatment center. We gave them treatment that is effective and here in a short time both are cured.” Muyembe said two new drugs “are now be used to treat Ebola patients because, according to the studies and the results we obtained in the lab, these are the two drugs that are effective.” Muyembe and other scientists announced this week that preliminary results from two trials in Congo found two drugs — made by Regeneron and the U.S. National Institutes of Health — seem to be saving lives. Researchers said more study is needed to nail down how well those two compounds work. The drugs are antibodies that block Ebola. In the trial, significantly fewer people died among those given the Regeneron drug or the NIH’s, about 30%, compared to those who received another treatment. Esperance Nabintu rejoiced that she and her young son had survived Ebola. “May the Lord be praised, I thank the Lord very much. I and my child were sick with Ebola, but God has just healed us. “My brothers, we must not doubt. Ebola exists, “said Nabintu, whose husband was the second Ebola victim to die in Goma. No other Ebola death has been detected since then. After a public announcement that Nabintu and her son, Ebenezer Fataki, 1, had recovered from Ebola, the response team accompanied the two former patients their home in the Kiziba area, where the medical team educated the residents about proper Ebola treatment. There is less danger that Ebola will spread through Goma, the capital of North Kivu province with more than 2 million inhabitants, because about 200 contacts and suspected cases have been identified and have received proper medication, said Muyembe. He said people arriving in Goma are being monitored at the city’s entry points. “People who come from Beni and Butembo (nearby cities where there are many Ebola cases) must be carefully examined, “said Muyembe. “All of the 200 contacts we are following are doing well. We are waiting until the end of the 21-day surveillance period. We are at day 13, so there are still 8 days to go before we can say that Goma has won against Ebola.” Health officials have also vaccinated tens of thousands of people in Congo and surrounding countries in an attempt to stop the outbreak, but the virus has now continued to spread for more than a year. Response efforts have been repeatedly hampered by attacks on health workers and continuing mistrust among the affected communities; many people in the region don’t believe the virus is real and choose to stay at home when they fall ill, infecting those who care for them. ___ Follow Africa news at https://twitter.com/AP_Africa

Ex Output:
2 Ebola patients in Congo “cured” with drugs, say doctors.


Ex Input:
It’s good that the report states the price of the device–above $200,000–and that at least one insurer does not pay for its use. But the story should have stated what it costs a patient to get treated with the device, and who bears any additional costs. The story says the device’s efficacy is uNPRoven, but it does not explore the body of inconclusive data. There is a 2007 study that shows 5 years of outcome data. The fact that that study did not demonstrate improved outcomes suggests the device does not have big, measurable benefits. The story would have been stronger had it referred to this study. The story reports that the extra time required to do a navigation-assisted surgery may lead to more complications. The story would have been stronger if it had mentioned the potential risks associated with the surgeon learning curve. The story does an excellent job of stating, plainly and repeatedly, that there is no conclusive evidence the surgical device improves outcomes. The story doesn’t exaggerate the severity or prevalence of the underlying joint conditions. Neither does it make false claims for the relief the device can provide. The story does use one positive anecdote, which could be read to mean the navigational device contributed to the positive outcome. The reality is that most patients do very well with the surgery without the need for a navigational prompt to the surgeon.But since the story states repeatedly that the technology’s benefits are uNPRoven, this is not a serious flaw. The reporter interviewed four surgeons, three of whom use the device and one of whom does not. The reporter did not quote the device maker, an impressive show of restraint. A key shortcoming: The reporter did not explore potential conflicts of interest of the sources. Doctors who are early adopters of expensive new technologies often have relationships with the device makers. So do the medical facilities where the doctors practice. Such relationships should have been disclosed, or the lack of relationship should have been plainly stated. The story indicates that most surgeries are done without the navigation device, and that other similar devices are in development. The story names four Iowa institutions that have the computer assisted surgery device. It also names four surgeons who use it. Ideally the story would stated how many of the devices are in use in Iowa, Des Moines or the U.S. But the story includes sufficient information to be rated satisfactory under this criterion. The report makes clear that the device has been in use for a few years but is still considered investigational. By reporting how many surgeries certain centers and surgeons have done with the device, the story provides an adequate view of its clinical use. There is no evidence that the story relied solely or largely on a news release.

Ex Output:

GPS-like system helps surgeons align joints